The Clinical Trials Office (CTO) is responsible for the management of:

  1. All RBHS related agreements required for the conduct of current or future early feasibility and Phase I-IV clinical trials.
  2. Studies with billable clinical procedures between Rutgers and a for-profit pharmaceutical or device company funding (or studies where devices or drugs are provided by sponsors free of charge)
  3. Where Rutgers is serving as the sponsor of an applicable clinical trial

This includes any related clinical trial site agreements and any associated work order and research plan agreements with its affiliated hospital institutions. This also includes any faculty or physician-investigator whose primary appointment is with RBHS, and in most cases not to include those whose primary appointment lies with CINJ.  

To learn more about the contracting process, view the budget and contracting SOP.

If you are not sure whether your contract needs are in the Clinical Trials Office scope, contact